National decline in invasive prenatal diagnostic procedures in association with uptake of combined first trimester and cell-free DNA aneuploidy screening

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 55, Issue 5, 2015, Pages 507-510

  Robson, Stephen J ^a   Hui, Lisa ^b,c,d  

^a The Australian National University   (Australia)

^b MERCY HOSPITAL FOR WOMEN   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

amniocentesis; cell free DNA; chorionic villus sampling; noninvasive prenatal testing; population; prenatal testing

Indexed keywords

AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; AUSTRALIAN; CHORION VILLUS SAMPLING; DNA SCREENING; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INVASIVE PROCEDURE; MATERNAL AGE; MEDICARE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REIMBURSEMENT; SCREENING TEST; UNITED STATES; ADULT; AUSTRALIA; CELL FREE SYSTEM; CHI SQUARE DISTRIBUTION; CONFIDENCE INTERVAL; FACTUAL DATABASE; INCIDENCE; ODDS RATIO; PREGNANCY; PROCEDURES; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

DNA;

ADULT; AMNIOCENTESIS; ANEUPLOIDY; AUSTRALIA; CELL-FREE SYSTEM; CHI-SQUARE DISTRIBUTION; CHORIONIC VILLI SAMPLING; CONFIDENCE INTERVALS; DATABASES, FACTUAL; DNA; FEMALE; HUMANS; INCIDENCE; MEDICARE; ODDS RATIO; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84942988930     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/ajo.12380     Document Type: Article

References (18)

1. O'Leary P, Breheny N, Reid G, et al., Regional variations in prenatal screening across Australia: stepping towards a national policy framework. Aust N Z J Obstet Gynaecol 2006; 46: 427-432.
2. Hui L, Teoh M, da Silva Costa F, et al., Clinical implementation of cell-free DNA-based aneuploidy screening: perspectives from a national audit. Ultrasound Obstet Gynecol 2015; 45: 10-15.
3. Larion S, Warsof SL, Romary L, et al., Association of combined first-trimester screen and noninvasive prenatal testing on diagnostic procedures. Obstet Gynecol 2014; 123: 1303-1310.
4. Hui L, Muggli EE, Halliday JL,. Population-based trends in prenatal screening and diagnosis for aneuploidy: a retrospective analysis of 38 years of state-wide data. BJOG 2015; June 25. doi: 10.1111/1471-0528.13488. [Epub ahead of print].
5. Australian Institute of Health and Welfare. Australia's Mothers and Babies Series. [Accessed 16 April 2015] Available from URL http://www.aihw.gov.au/publications/.
6. Australian Bureau of Statistics. Births, Summary, States and Territories. [Accessed 23 November 2014.] Available from URL http://www.abs.gov.au/AUSSTATS/abs@nsf/DetailsPage/3301.02013?OpenDocument
7. Medical Services Advisory Committee (MSAC). Nuchal translucency measurement in the first trimester of pregnancy for screening of trisomy 21 and other autosomal trisomies. MSAC reference 04 Assessment Report (approval 3142), May 2002. Commonwealth of Australia, published August 2003.
8. https://www.nhmrc.gov.au/guidelines-publications/e72
9. O'Leary PC, Bower C, Crowhurst J, et al., The impact of maternal serum screening for Down syndrome in Western Australia: 1980-94. Aust N Z J Obstet Gynaecol 1996; 36: 385-388.
10. Zoppi MA, Ibba RM, Putzolo M, et al., Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older. Obstet Gynecol 2001; 97: 916-920.
11. Muller PR, Cocciolone R, Haan EA, et al., Trends in state/population based screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005. Am J Obstet Gynecol 2007; 196: 315.
12. Wray AM, Ghidini A, Alvis C, et al., The impact of first-trimester screening on AMA patients' uptake of invasive testing. Prenat Diagn 2005; 25: 350-353.
13. Cicero S, Avgidou K, Rembouskos G, et al., Nasal bone in first-trimester screening for trisomy 21. Am J Obstet Gynecol 2006; 195: 109-114.
14. Chetty S, Garabedian MJ, Norton ME,. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenat Diagn 2013; 33: 542-546.
15. Bianchi D, Parker RL, Wentworth J, et al., DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014; 370: 799-808.
16. Norton ME, Jacobsson BO, Swamy GK, et al., Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015; 372: 1589-1597.
17. International Society for Prenatal Diagnosis. Position Statement from the Chromosome Abnormality Screening Committee on Behalf of the Board of the International Society for Prenatal Diagnosis 2015. [Accessed 20 April 2015] Available from URL http://www.ispdhome.org/public/news/2015/PositionStatementFinal04082015.pdf
18. Hui L, Teoh M, Piessens S, Walker SP,. Early clinical experience of cell-free DNA-based aneuploidy screening: a survey of obstetric sonologists in Australia and New Zealand. Aust N Z J Obstet Gynaecol 2015; 55: 138-143.